Balyasny Asset Management
MD icon

Balyasny Asset Management’s Pediatrix Medical MD Stock Holding History

Balyasny Asset Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-146,400
Closed -$9.76M – 1709
2016
Q4 		$9.76M Buy
+146,400
New +$9.52M 0.05% 481

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Balyasny Asset Management's MD Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Pediatrix Medical (MD) in Q1 2026: 10,860 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #2652 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in MD as recently as Q2 2025.

Balyasny Asset Management first reported a position in MD in Q3 2015 and has held it in 14 quarters since. The position peaked at $64M in Q2 2017. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Balyasny Asset Management held 10,860 shares of Pediatrix Medical worth $232K as of Q1 2026.
  • Pediatrix Medical was a new Balyasny Asset Management position in Q1 2026.
  • Pediatrix Medical made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2652 holding.
  • Balyasny Asset Management first reported a position in Pediatrix Medical in Q3 2015 and has held it in 14 quarters since.
  • Balyasny Asset Management's Pediatrix Medical position peaked at $64M in Q2 2017.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.